FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 1766339 · Received July 21, 2010

Report

Report Number
2124215-2010-13012
Event Type
Malfunction
Date Received
July 21, 2010
Date of Event
June 2, 2010
Report Date
June 3, 2010
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
PMA / PMN Number
P960040
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NC
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE PATIENT UNDERWENT DEFIBRILLATION THRESHOLD TESTING (DFT). THE DFT TESTING RETURNED IMPEDANCE MEASUREMENTS WITHIN RANGE ONCE THE COMPETITORS LEAD WAS ELECTRONICALLY DEACTIVATED. THE DFT TESTING WAS SUCCESSFUL IN A SINGLE COIL CONFIGURATION. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THIS DEVICE DETECTED HIGH, OUT OF RANGE SHOCK IMPEDANCES ON A COMPETITOR'S SUBCUTANEOUS ARRAY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 63 YR 0181| 6996SQ| 4135| E110| 0185